A Persian AI-Based CBT Chatbot and Voice Analysis System for Managing Perceived Stress
PersianAI-CBT
Design and Evaluation of an Intelligent Mental Health System Based on Voice Analysis and an Empathetic Cognitive Behavioral Therapy (CBT) Chatbot for Perceived Stress Management: A Three-Arm Pilot Randomized Controlled Trial
1 other identifier
interventional
120
1 country
1
Brief Summary
This pilot randomized controlled trial aims to evaluate a Persian-language artificial intelligence (AI)-based cognitive behavioral therapy (CBT) chatbot designed to support adults in managing perceived stress. A total of 120 adults will be randomly assigned to one of three groups: an AI-based CBT chatbot intervention, active mental health educational content, or a waitlist control. The intervention period will last 14 days. The study will evaluate the feasibility, acceptability, safety, and preliminary effectiveness of the AI-based CBT chatbot for perceived stress management. As a separate research component, voice recordings will be collected from participants at baseline and at the end of the study. These recordings will be used solely as research data to train and evaluate an artificial intelligence model for stress detection. The voice-based model will not be used to guide, modify, personalize, or influence the study intervention, chatbot responses, participant allocation, or clinical decision-making during this trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedStudy Start
First participant enrolled
October 5, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
Study Completion
Last participant's last visit for all outcomes
February 1, 2027
September 25, 2026
September 1, 2026
4 months
September 18, 2026
September 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Perceived Stress Scale-10 (PSS-10) Score
Change in total Perceived Stress Scale-10 (PSS-10) score from baseline to Day 14. The PSS-10 is used to assess perceived stress, with higher scores indicating greater perceived stress. Changes in PSS-10 scores will be compared across the three study groups.
Baseline and Day 14
Secondary Outcomes (2)
Change in DASS-21 Stress Subscale Score
Baseline and Day 14
Number of Completed Intervention Sessions
Throughout the 14-day intervention period
Study Arms (3)
AI-Based CBT Chatbot
EXPERIMENTALParticipants assigned to this arm will receive an interactive Persian-language AI-based CBT chatbot intervention during the 14-day study period. The chatbot will provide structured CBT-based exercises and conversational support for stress management. The intervention will include psychoeducation, cognitive restructuring, coping strategies, behavioral techniques, and stress-management exercises. The chatbot will operate within predefined safety guardrails and crisis-management procedures.
Active Mental Health Content
ACTIVE COMPARATORParticipants assigned to this arm will receive structured, non-interactive mental health and stress-management content during the study period. The content will include psychoeducational material and general stress-management techniques but will not include adaptive or personalized conversational interaction with the AI-based CBT chatbot. The active comparator is intended to control for nonspecific intervention effects, including attention, expectancy, and exposure to mental health-related content. This is important because perceived stress may decrease simply as a result of receiving structured support and study-related attention. Including this arm allows the study to better distinguish the specific effects of the interactive AI-based CBT chatbot from improvements attributable to general attention and psychoeducational exposure.
Waitlist Control
NO INTERVENTIONParticipants assigned to this arm will not receive an active psychological intervention during the 14-day study period. They will complete the scheduled study assessments and will remain subject to the study safety and referral procedures.
Interventions
A Persian-language artificial intelligence-based conversational intervention designed to provide structured support based on cognitive behavioral therapy principles for adults with mild to moderate perceived stress. The chatbot delivers interactive CBT-based exercises, including psychoeducation, identification and restructuring of maladaptive thoughts, coping strategies, behavioral techniques, and stress-management exercises. The intervention is delivered during a 14-day period and incorporates predefined safety guardrails and crisis-management procedures.
Structured, non-adaptive mental health and stress-management educational content provided during the study period. The content is designed to provide general psychoeducation and stress-management support without personalized AI-generated dialogue or adaptive CBT interaction.
Eligibility Criteria
You may qualify if:
- Age between 18 and 45 years
- Mild or moderate perceived stress based on the Perceived Stress Scale-10 (PSS-10) screening assessment
- Ability to use a smartphone
- Access to the internet during the study period
- Ability and willingness to provide electronic informed consent
- Willingness to participate in study assessments and complete the required study procedures
You may not qualify if:
- Severe perceived stress at the initial screening assessment
- Active suicidal ideation or risk of self-harm
- Acute psychological crisis requiring immediate professional intervention
- Active psychosis
- Active mania
- Severe substance use disorder
- Psychiatric hospitalization in recent months
- Initiation of a new psychiatric medication or change in the dose of a psychiatric medication within the previous four weeks
- Concurrent participation in intensive psychotherapy or another intensive psychological intervention
- Any mental health condition requiring immediate specialist evaluation or treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Isfahancollaborator
- Hamid Reza Marateblead
- Isfahan University of Medical Sciencescollaborator
Study Sites (1)
Isfahan University of Medical Sciences
Isfahan, Isfahan, Iran
Related Publications (3)
Naslund JA, Aschbrenner KA, Araya R, Marsch LA, Unutzer J, Patel V, Bartels SJ. Digital technology for treating and preventing mental disorders in low-income and middle-income countries: a narrative review of the literature. Lancet Psychiatry. 2017 Jun;4(6):486-500. doi: 10.1016/S2215-0366(17)30096-2. Epub 2017 Apr 19.
PMID: 28433615RESULTSchneiderman N, Ironson G, Siegel SD. Stress and health: psychological, behavioral, and biological determinants. Annu Rev Clin Psychol. 2005;1:607-28. doi: 10.1146/annurev.clinpsy.1.102803.144141.
PMID: 17716101RESULTTorous J, Bucci S, Bell IH, Kessing LV, Faurholt-Jepsen M, Whelan P, Carvalho AF, Keshavan M, Linardon J, Firth J. The growing field of digital psychiatry: current evidence and the future of apps, social media, chatbots, and virtual reality. World Psychiatry. 2021 Oct;20(3):318-335. doi: 10.1002/wps.20883.
PMID: 34505369RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammad Reza Sharbafchizadeh
Behavioural Sciences Research Center & Department of Psychiatry, Khorshid Hospital, Isfahan University of Medical Sciences, Isfahan, Iran
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- articipants cannot be blinded because of the nature of the chatbot and active-content interventions. Investigators involved in intervention delivery may also be aware of group assignment
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor of Biomedical engineering, University of Isfahan
Study Record Dates
First Submitted
September 18, 2026
First Posted
September 25, 2026
Study Start (Estimated)
October 5, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
September 25, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
De-identified individual participant data underlying the reported study results may be shared. These may include selected questionnaire scores, demographic variables, intervention engagement measures, and derived non-identifiable acoustic features. Raw voice recordings will not be shared, transferred, or made available to external researchers under any circumstances. Full chatbot transcripts, crisis-related information, and data that could increase the risk of participant re-identification will also not be shared. A data dictionary will accompany any shared dataset.